Literature DB >> 16234549

Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer?

Lisa Licitra, Paolo Bossi, Laura D Locati, Cristiana Bergamini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16234549     DOI： 10.1200/JCO.2005.02.7854

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Comparison of narrow-band imaging and conventional nasopharyngoscopy for the screening of unaffected members of families with nasopharyngeal carcinoma.

Authors:  Ching-Yin Ho; Kee-Tak Chan; Pen-Yuan Chu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-23       Impact factor: 2.503

2.  Combination treatment with cetuximab in advanced nasopharyngeal carcinoma patients: a meta-analysis.

Authors:  Jia Shen; Changling Sun; Min Zhou; Zhen Zhang
Journal:  Onco Targets Ther       Date:  2019-04-03       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.